Jove
Visualize
Contact Us

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.0K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

103
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
103
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

770
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
770
Drug Therapy01:28

Drug Therapy

68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
68
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

130
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
130

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PSO-FeatureFusion: a general framework for fusing heterogeneous features via particle swarm optimization.

Bioinformatics advances·2025
Same author

Target controllability: a feed-forward greedy algorithm in complex networks, meeting Kalman's rank condition.

Bioinformatics (Oxford, England)·2024
Same author

MiRAGE: mining relationships for advanced generative evaluation in drug repositioning.

Briefings in bioinformatics·2024
Same author

NN-RNALoc: Neural network-based model for prediction of mRNA sub-cellular localization using distance-based sub-sequence profiles.

PloS one·2023
Same author

Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.

Journal of bioinformatics and computational biology·2021
Same author

A neural network-based method for polypharmacy side effects prediction.

BMC bioinformatics·2021
Same journal

metaLoc: protein localisation prediction workflow.

Bioinformatics advances·2026
Same journal

Fuscan: a robust DNA fusion caller for targeted sequencing data in cancer diagnostics.

Bioinformatics advances·2026
Same journal

Correction to: Pathogenicity patterns in cytochrome P450 family.

Bioinformatics advances·2026
Same journal

Region-aware bridge modeling enables interpretable mesoscale representation of spatial transcriptomic tissue sections.

Bioinformatics advances·2026
Same journal

Microbiome differential abundance methodologies to detect relevant taxa associated with chemotherapy toxicity rate in colorectal cancer.

Bioinformatics advances·2026
Same journal

maldipickr dereplicates microbial MALDI-TOF spectra to facilitate multiplexed isolation.

Bioinformatics advances·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 16, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

DPSP: a multimodal deep learning framework for polypharmacy side effects prediction.

Raziyeh Masumshah1, Changiz Eslahchi1,2

  • 1Department of Computer and Data Sciences, Faculty of Mathematical Sciences, Shahid Beheshti University, Tehran 1983969411, Iran.

Bioinformatics Advances
|September 13, 2023
PubMed
Summary
This summary is machine-generated.

Identifying drug-drug interaction (DDI) adverse effects is crucial for patient safety. The DPSP framework effectively predicts polypharmacy side effects using novel drug features and a deep neural network, outperforming existing methods.

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

Related Experiment Videos

Last Updated: Jul 16, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

Area of Science:

  • Pharmacology
  • Computational Biology
  • Artificial Intelligence

Background:

  • Unanticipated drug-drug interactions (DDIs) pose significant health risks.
  • Identifying polypharmacy's adverse effects is a critical challenge in human health.
  • Computational methods for predicting polypharmacy side effects have advanced.

Purpose of the Study:

  • To present DPSP, a novel framework for predicting polypharmacy side effects.
  • To develop a deep neural network approach for DDI prediction.
  • To generate novel drug features for improved DDI identification.

Main Methods:

  • Drug information evaluation and feature extraction using Jaccard similarity.
  • Generation of novel drug feature vectors by combining similarities.
  • Application of a multimodal deep neural network framework for DDI prediction.

Main Results:

  • DPSP demonstrated superior performance compared to established methods like GNN-DDI, MSTE, and DNN on benchmark datasets.
  • The framework achieved high accuracy across various classification metrics.
  • Diverse drug information integration proved effective for DDI adverse effect identification.

Conclusions:

  • The DPSP framework offers an effective and efficient solution for predicting polypharmacy side effects.
  • Leveraging diverse drug information enhances DDI prediction accuracy.
  • The study highlights the potential of deep learning in mitigating DDI risks.